Yoshimi N, Shimizu M, Matsunaga K, Yamada Y, Fujii K, Hara A, Mori H
Department of Pathology, Gifu University School of Medicine.
Jpn J Cancer Res. 1999 Apr;90(4):406-12. doi: 10.1111/j.1349-7006.1999.tb00762.x.
Non-steroidal anti-inflammatory drugs (NSAIDs) such as sulindac and indomethacin inhibit colon carcinogenesis, and selective cyclooxygenase (COX)-2 inhibitors are considered to be potential chemopreventive agents without the side effects of usual NSAIDs. We reported that NS-398, N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide, suppressed the formation of preneoplastic lesions, aberrant crypt foci (ACF), induced by azoxymethane (AOM) in a short-term assay of rat colon carcinogenesis. In this study, we examined the effects of long-term NS-398 administration on rat colon carcinogenesis. After three AOM treatments at weekly intervals, a dose of 10 mg/kg of NS-398 in 5% Arabic gum solution was administered by gavage three times per week in group 2 until the termination of the experiment. Rats in group 1 were fed in a basal diet and given 5% Arabic gum solution alone after AOM treatment. At 40 weeks after the first AOM treatment, all rats were killed and the whole intestines including colon were examined. While the incidences of whole intestinal and colon neoplasms in group 1 were 84.6% and 80.8%, respectively, those in group 2 (given NS-398) were 51.9% and 44.4% respectively (P=0.0177 and P=0.0103 by Fisher's exact test, respectively). The multiplicities in group 2 (0.67+/-0.78 and 0.48+/-0.58) were also decreased significantly compared with those (1.39+/-1.10 and 1.08+/-0.74) in group 1 (P<0.01 by Welch's method and P<0.002 by Student's t test, respectively). In immunohistochemistry for proliferative cell nuclear antigen (PCNA), the PCNA-stained cell index (7.40+/-0.5) in group 2 was significantly decreased from that in group 1 (14.03+/-0.82) (P<0.001 by Welch's method). The results suggest that NS-398, a selective COX inhibitor, has a chemopreventive activity against colon carcinogenesis without side-effects such as gastric ulceration.
舒林酸和吲哚美辛等非甾体抗炎药(NSAIDs)可抑制结肠癌发生,选择性环氧化酶(COX)-2抑制剂被认为是潜在的化学预防剂,且无普通NSAIDs的副作用。我们曾报道,NS-398,即N-(2-环己氧基-4-硝基苯基)甲磺酰胺,在大鼠结肠癌发生的短期试验中,可抑制由氧化偶氮甲烷(AOM)诱导的癌前病变——异常隐窝灶(ACF)的形成。在本研究中,我们检测了长期给予NS-398对大鼠结肠癌发生的影响。在每周间隔进行三次AOM处理后,第2组大鼠每周经口灌胃给予三次5%阿拉伯胶溶液配制的10 mg/kg NS-398,直至实验结束。第1组大鼠给予基础饮食,并在AOM处理后单独给予5%阿拉伯胶溶液。在首次AOM处理后40周,处死所有大鼠,检查包括结肠在内的整个肠道。第1组全肠道和结肠肿瘤的发生率分别为84.6%和80.8%,而第2组(给予NS-398)分别为51.9%和44.4%(Fisher精确检验,P分别为0.0177和0.0103)。与第1组(1.39±1.10和1.08±0.74)相比,第2组(0.67±0.78和0.48±0.58)的肿瘤数量也显著减少(分别采用Welch法和Student t检验,P<0.01和P<0.002)。在增殖细胞核抗原(PCNA)免疫组化中,第2组的PCNA染色细胞指数(7.40±0.5)显著低于第1组(14.03±0.82)(采用Welch法,P<0.001)。结果表明,选择性COX抑制剂NS-398对结肠癌发生具有化学预防活性,且无胃溃疡等副作用。